imedilane: Financial Breakdown
Decoding financial health metrics of imedilane
- Total Expenses₹1.1K-79%
Prev. FY
- Profit After Tax₹-1.1K78%
Prev. FY
- Total Assets₹10.1 Lakh-3%
Prev. FY
FAQs on Financials of imedilane
No. In FY18, imedilane reported a net loss of ₹7.9 Lakh, so it was not profitable.
imedilane's revenue declined 3.4% year-on-year, from ₹4.5 Lakh in FY17 to ₹4.4 Lakh in FY18.
In FY18, imedilane posted revenue of ₹4.4 Lakh (down 3.4% YoY) and a net loss of ₹7.9 Lakh. Explore the full financials of imedilane here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links

